EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY Dr. Inga Dadeshidze Science Officer COST Administration Sent by for BM1309 MC / WG Meeting 2-3/10/2014, Split, Croatia Sincere apologies for not being able to attend Wish you very fruitful and successful Meeting

COST POLICIES H2020 2

COST Policies under H2020  Inclusiveness  Early stage researchers, ESRs  Gender balance  International cooperation  SMEs/industry participation 3 COST has identified its priorities and developed its policies on:

COST Inclusiveness Policy 4 Originated from:  Political context of Horizon  Geographical context of the COST Member Countries. With the aim to:  Encourage and enable researchers from less research- intensive countries across the COST Member Countries to set up and/or join COST Actions and get more intensively involved in all COST activities.  Counterbalancing research communities’ unequal access to knowledge infrastructures, funding and resources distribution.

COST Inclusiveness countries 5

 Leadership roles at Action level.  Locating Action meetings, workshops & conferences.  Promoting STSMs tool in these countries.  Benefiting from COST networking tools.  Strategy of the Action in order to attract top-scientist from target countries. 6 IMPLEMENTATION at MC Level: Inclusiveness SOME EXAMPLES: The ACTION should have a plan towards inclusiveness that should be revised an updated at every MC meeting.

 Set a target figure, from which a percentage of the Action budget shall be used for ESRs-STSMs.  Special STSMs for Early Stage Researchers: up to 6 months with a grant of up to EUR.  Specific Support for Training Schools.  An early stage researchers' network may be created within the Action as a “think tank”.  Leadership roles at Action level (WG leaders…). 7 IMPLEMENTATION at MC Level: SOME EXAMPLES: Early Stage Researchers (PhD + max. 8 years) The ACTION should have a plan for the involvement of ESR that should be revised and updated at every MC meeting.

Gender balance With the aim to:  Encourage and enable under represented gender to be intensively involved in all COST activities.  Networking the way to gender equality in science and technology. 8 IMPLEMENTATION at MC Level: SOME EXAMPLES:  Leadership roles at Action level (WG leaders…)  Gender balance in allocation of STSMs  Active promotion of STSMs to ESRs of under-represented gender  Gender balance in allocation of Training School Trainee grants  Gender balance in allocation of meeting reimbursement places

International Cooperation With the aim to:  to support the involvement of researchers from Near Neighbour and International Partner countries in COST Actions on the basis of mutual benefit. 9 IMPLEMENTATION at Action Level: SOME EXAMPLES:  Approved IPC and NNC institutions can host STSMs  Researcher from Approved NNC institutions can:  Apply for STSM  Attend Training Schools  Researchers from Approved IPC and NNC institutions can be trainers COST 4115/13: COST International Cooperation Rules

 Facilitate/ encourage industry/ stakeholder participation – eg programme has a half/ full day focussed just on industry-relevant issues 10 SMEs & Industry

COST Would you like to participate in COST Action or in other COST activities? 11

12

BMBS COST New Actions 13

 BIOMEDICINE & MOLECULAR BIOSCIENCES DOMAIN  TRANS-DOMAIN

 COST NATIONAL COORDINATOR  Science Officer  ACTION CHAIR 15 Dr Inga Dadshidze, SO Dr Mafalda Quintas, SO TD Dr Giuseppe Lugano, SO TD

Domain BMBS 16 Biomedicine and Molecular Biosciences 42 running - 4 New Actions BMBS covers all fields and areas of medicine and biomedical sciences as practiced in Europe from basic and preclinical to cliical research developed to translate the “bench to bedside” concept.

Biomedicine and Molecular Biosciences BMBS 17 Molecular Biosciences: Basic and applied biomolecular research; All areas of genomics, proteomics and metabolomics (structures and functions); Study of the Central Nervous System and neuronal connections, cognitive neuroscience; immune system, cell migration, cell dysfunctions, cellular mechanisms of diseases Molecular Biosciences: Basic and applied biomolecular research; All areas of genomics, proteomics and metabolomics (structures and functions); Study of the Central Nervous System and neuronal connections, cognitive neuroscience; immune system, cell migration, cell dysfunctions, cellular mechanisms of diseases Biomedicine and Specific Technologies: advanced imaging and treatment techniques (basic research, diagnosis, treatment procedures), medical devices and new medicines, advanced medical research on biomaterials Micro- and Nanomedicine (including nanotechnologies), biomedicine/ molecular bioscience and pharmacologyinterdisciplinary issues in the fields such as bioinformatics, biomedical engineering, medical physics and chemistry, mathematical models in medicine.

18 BM1401 – Raman4clinics: Raman-based applications for clinical diagnostics Network of researchers in 17 countries up to now Start date: 9 December 2014 End date: 8 December 2018 Proposer: Professor Jürgen POPP Leibniz Institute of Photonic Technology, DE

19 BM1401 – Raman4clinics: Raman-based applications for clinical diagnostics Therapeutic Drug Monitoring Diagnosis of Infectious Diseases Identification of Circulating Tumor Cells Histopathology Of Cells And Tissue Sections Fiber Optic Endoscopy

20 BM1402 – Development of a European network for preclinical testing of interventions in mouse models of age and age-related diseases (MouseAGE) Network of researchers in 18 countries up to now Start date: 1 December 2014 End date: 30 November 2018 Proposer: Prof Ilaria Belantuono University of Sheffield, UK

21 BM1403 – Native Mass Spectrometry and Related Methods for Structural Biology Network of researchers in 10 countries up to now Start date: 26 November 2014 End date: 25 November 2018 Proposer: Professor Frank SOBOTT Center for Proteomics, University of Antwerp, BE

22 BM1404 – Mye-EUNITER: European Network of Investigators Triggering Exploratory Research on Myeloid Regulatory Cells Network of researchers in 15 countries up to now Start date: 27 November 2014 End date: 26 November 2018 Proposer: Professor Sven BRANDAU University Duisburg-Essen, DE

Are you already in contact with other researchers and you would like to submit a COST Action proposal? 23

COST Open Call  Next collection date: March 2015  Stay tuned for COST updates:

OPTION 3 Become a COST EXPERT 25

Become a COST Expert! 26 As a COST Expert, you will have the opportunity to: Contribute to the evaluation of COST Open Call proposals; Participate in the assessment of Action results and outcomes; Be invited to take part in the assessment of COST strategic activities.. As a COST Expert, you will have the opportunity to: Contribute to the evaluation of COST Open Call proposals; Participate in the assessment of Action results and outcomes; Be invited to take part in the assessment of COST strategic activities.. New experts can express their interest via the COST Expert online registration form ( An updated Curriculum Vitae with a list of publications is required to demonstrate competence in specific areas of expertise. More on COST Experts:

COST – European Cooperation in Science and Technology Avenue Louise Brussels, Belgium T: +32 (0) F: +32 (0) Get COST News by by signing up at twitter.com/COSToffice